[3] It is important to recognize and diagnose the association of H. heilmannii sensu lato with these upper gastrointestinal tract diseases, particularly extranodal marginal zone lymphoma of the stomach, because many of them have been successfully treated using antibiotic-based drug regimens directed against the instigating H. heilmannii sensu lato bacterial species.
is Helicobacter heilmannii bacterial species that have been isolated from the stomachs of humans and animals, but identified only on the basis of their histopathological appearance, electron microscopic appearance, and/or other crude taxonomic data: in most studies, the species of these H. heilmannii bacteria is not defined other than that they are non-H. pylori isolated from the stomachs of humans and animals.
H. heilmanni s.s., in contrast, is Helicobacter heilmannii isolates whose species have been clearly defined, typically by unambiguous molecular biology methods.
infections by close contact with cats, dogs, pigs, and other farm animals, as well as by eating raw pork contaminated by H.
Based on the ability of antibiotic-based drug regimens to improve and cure some of these diseases in humans and animal models, H. heilmanni s.l.
bacterium in the stomach to achieve symptomatic relief and total regression of some of the infection-associated nonmalignant, as well as malignant diseases, particularly extranodal marginal B-cell lymphoma.
[3] Drug regimens of amoxicillin, clarithromycin, plus a proton pump inhibitor[6] or metronidazole, clarithromycin, plus a proton pump inhibitor[3] have been used to treat S. heilmannii s.l.-associated upper gastrointestinal tract diseases successfully.